lofexidine
Alpha-Adrenergic Agonist Mitigates Abrupt Opioid Discontinuation–Related Withdrawal
For clinicians on the front line of the opioid crisis, there may be a new weapon against the significant symptom ...
AUGUST 29, 2019
First Nonopioid Treatment for Withdrawal Approved by FDA
The FDA approved lofexidine hydrochloride, a first-of-its-kind nonopioid for treatment of opioid withdrawal.
MAY 18, 2018
FDA Committee Recommends Approval of Lofexidine for Opioid Withdrawal
In a nearly unanimous vote, an FDA committee recently recommended approval of lofexidine (Lucemyra, US WorldMeds), ...
APRIL 4, 2018
Load more